Dr. Heather M. Eschbach, DO

Dr. Eschbach practices at SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri.

Dr. Eschbach's NPI, 1013477454, was assigned on March 21, 2019. Dr. Eschbach holds Missouri license 2022044642.

Dr. Eschbach's primary practice is SLUCare Physician Group Dermatology Pathology, at 1225 S Grand Blvd, 3rd Floor, Saint Louis, MO 63104. The practice phone is (314) 617-2709.

Dr. Eschbach's primary practice is SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri. Dr. Eschbach is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Eschbach to 2 more hospitals, 1 clinical lab and 1 group practice or clinic, each named with a free account. Dr. Eschbach's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eschbach practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Eschbach's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Eschbach is licensed in Missouri.

CMS data shows 107 Medicare services from Dr. Eschbach across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $6,626 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Eschbach in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eschbach's median patient age at 64, with 65% women.

In 2024, Dr. Eschbach wrote 444 Medicare Part D claims for 74 patients. 86% of them were for generic drugs. CMS names the drug for 194 of them, across 13 drugs with 11 or more claims each, at $11,759 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Eschbach for performance year 2024, reported as part of a group. Dr. Eschbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.